Headline News about AbbVie![]() ![]() ![]() ![]() ![]() ![]()
Looking Into AbbVie's Recent Short Interest
October 12, 2023
Via Benzinga
![]()
Looking At AbbVie's Recent Unusual Options Activity
October 11, 2023
Via Benzinga
![]()
AbbVie Unusual Options Activity
October 09, 2023
Via Benzinga
![]()
Should You Load Up On This 1 Dividend Stock?
October 06, 2023
Via The Motley Fool
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Check Out What Whales Are Doing With ABBV
October 03, 2023
Via Benzinga
![]()
What 4 Analyst Ratings Have To Say About AbbVie
September 29, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|